Charles Schwab
IMNN icon

Charles Schwab’s Imunon IMNN Stock Holding History

Charles Schwab’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-251
Closed -$63K – 3526
2021
Q2 		$63K Buy
251
+163
+185% +$38.5K ﹤0.01% 3336
2021
Q1 		$24K Hold
88
– – ﹤0.01% 3482
2020
Q4 		$13K Hold
88
– – ﹤0.01% 3388
2020
Q3 		$13K Hold
88
– – ﹤0.01% 3327
2020
Q2 		$64K Buy
+88
New +$38.2K ﹤0.01% 3253

Other funds holding IMNN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eudaimonia Partners Winchester, Tennessee $420M AUM 27.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Charles Schwab's IMNN Position: Q3 2021 in Review

Charles Schwab sold out of Imunon (IMNN) in Q3 2021, closing a stake of 251 shares — an estimated $63K sold.

Charles Schwab first reported a position in IMNN in Q2 2020 and held it in 5 quarters. The position peaked at $64K in Q2 2020. 37 funds tracked by Wall St. Rank hold IMNN as of Q3 2021.

  • Charles Schwab reported no remaining Imunon position as of Q3 2021 after selling out during the quarter.
  • Charles Schwab sold 251 Imunon shares in Q3 2021, an estimated $63K.
  • Charles Schwab first reported a position in Imunon in Q2 2020 and held it in 5 quarters.
  • Charles Schwab's Imunon position peaked at $64K in Q2 2020.
  • 37 funds tracked by Wall St. Rank held Imunon as of Q3 2021.

Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.